Schering-Plough CEO looks to Vytorin and Zetia to boost bottom line
Schering-Plough is looking to its cholesterol treatments Vytorin and Zetia to help boost earnings for the next several years as ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.